🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This phase II trial studies how well the addition of nemtabrutinib to lisoc...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07194980
Treatments Being Tested
This phase II trial tests how well adding lisocabtagene maraleucel (liso-ce...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2023-06-02
Trial ID
NCT05672173
This is a First in Human (FIH) Phase I/II, multinational, multicenter, open...
Status
Completed
Location
O'Neal Comprehensive Cancer Center at UAB
Start Date
2019-12-11
Trial ID
NCT04180215
Treatments Being Tested
"This phase I trial investigates the effect of radiation therapy on the imm...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2022-06-20
Trial ID
NCT05371132
MK-8294, the study medicine, is a type of targeted therapy designed to trea...
Status
Recruiting
Location
Northwestern University ( Site 0101)
Start Date
2025-07-23
Trial ID
NCT07030712
The purpose of this study is to evaluate the safety of repeat doses ⁸⁹Zr-Df...
Status
Completed
Location
University of Alabama-Birmingham Hospital
Start Date
2018-12-18
Trial ID
NCT03802123
Treatments Being Tested
This prospective, single-center pilot study is being performed to find out ...
Status
Not Yet Recruiting
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2026-10-01
Trial ID
NCT07700121
A Phase I/IIa First-in-human, Open-label Study to Evaluate the Safety, Phar...
Status
Terminated
Location
Research Site
Start Date
2022-06-07
Trial ID
NCT05397171
Treatments Being Tested